Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivoYusuke Tarumoto, Christopher R. Vakoc|Blood|2019Cited by 81
KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangementsYan Zi Au, Kosuke Yusa, Étienne De Braekeleer et al.|Leukemia|2020Cited by 52
The Salt-Inducible Kinase inhibitor YKL-05-099 suppresses MEF2C function and acute myeloid leukemia progression <i>in vivo</i>Yusuke Tarumoto, Christopher R. Vakoc|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 1